2020 RIS Research Grants for UMN

Rein in Sarcoma proudly announces a $150,000 research grant approved by the Rein in Sarcoma Board on January 27, 2020. This brings the cumulative research funding by Rein in Sarcoma to $2 million since the organization’s founding in 2001. This grant will fund the following three exciting University of Minnesota Masonic Cancer Center projects: “eBAT…

2019 RIS Research Grants for UMN

Rein in Sarcoma proudly announces a $150,000 research grant approved by the Rein in Sarcoma Board in January, 2019. This grant will fund the following three exciting University of Minnesota Masonic Cancer Center projects: “MYOG Promoter-Controlled Oncolytic Adenovirus to Treat PAX3-FOXO1-Positive Rhabdomyosarcoma” | $50,000 Principle Investigator: Masato Yamamoto, MD, PhD Co-Investigator: H Yoshida, MD, PhD…

Sarcoma Coalition

Sarcoma cancers are rare cancers with all too few organizations working to support sarcoma patients, educate the public and the medical community and to fund research for cures. There are less than ten broad based sarcoma organizations (such as Rein in Sarcoma) and several dozen organizations supporting specific sarcoma sub-types (such as Osteosarcoma, Rhadosarcoma or…

2018 RIS Research Grants for UMN

“Predicting relapse and response to chemotherapy in sarcoma.” | $49,000 Principal Investigator: Amy Skubitz, PhD – Professor of Laboratory Medicine and Pathology, Professor of Obstetrics, Gynecology and Women’s Health, University of Minnesota Summary: Predicting the behavior of a sarcoma tumor in a patient is of critical importance in their care. When a primary tumor is…